These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2533158)

  • 1. LHRH analogues in combination with an anti-androgen in the treatment of advanced disease.
    Denis L
    Horm Res; 1989; 32 Suppl 1():66-7; discussion 68. PubMed ID: 2533158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.
    Schulze H; Kaldenhoff H; Senge T
    Urol Int; 1988; 43(4):193-7. PubMed ID: 2973169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinising hormone-releasing hormone analogues alone in the treatment of advanced disease.
    Debruyne F
    Horm Res; 1989; 32 Suppl 1():62-4; discussion 64-5. PubMed ID: 2533157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
    Schulze H; Senge T
    J Urol; 1990 Oct; 144(4):934-41. PubMed ID: 2144596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
    Di Silverio F; Sciarra F; D'Eramo G
    Eur Urol; 1990; 18(1):10-5. PubMed ID: 2144819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of prostatic cancer.
    Huben RP; Perrapato SD
    Drugs Aging; 1991; 1(5):353-63. PubMed ID: 1838950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    Lunglmayr G
    Eur Urol; 1990; 18 Suppl 3():28-9. PubMed ID: 2151273
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
    Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
    Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximal androgen blockade in prostatic cancer.
    Denis L
    Scand J Urol Nephrol Suppl; 1991; 138():137-44. PubMed ID: 1838427
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine therapy for advanced stage D prostate cancer.
    Taylor TK
    Urol Nurs; 1991 Sep; 11(3):22-6. PubMed ID: 1833823
    [No Abstract]   [Full Text] [Related]  

  • 11. Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
    Bouffioux C
    Eur Urol; 1988; 15(3-4):187-92. PubMed ID: 2975222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the luteinising hormone-releasing hormone (LHRH) analogue, Zoladex.
    Furr BJ
    Horm Res; 1989; 32 Suppl 1():86-92. PubMed ID: 2533160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
    Waxman J
    Prog Clin Biol Res; 1989; 303():61-8. PubMed ID: 2528741
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
    Moffat LE
    Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
    [No Abstract]   [Full Text] [Related]  

  • 16. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
    Lunglmayr G
    Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine treatment of prostate cancer.
    Turkes AO; Griffiths K
    Prog Med Chem; 1989; 26():299-321. PubMed ID: 2532376
    [No Abstract]   [Full Text] [Related]  

  • 19. Goserelin acetate implant: a depot luteinizing hormone-releasing hormone analog for advanced prostate cancer.
    Goldspiel BR; Kohler DR
    DICP; 1991; 25(7-8):796-804. PubMed ID: 1835221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of reversible androgen suppression as a diagnostic test.
    Newling DW
    Prog Clin Biol Res; 1987; 243A():261-5. PubMed ID: 2958858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.